A61K 49/0045
The fluorescent agent being a peptide or protein used for imaging or
Official title: {the fluorescent agent being a peptide or protein used for imaging or diagnosis in vivo}
A61K49/0045 (The fluorescent agent being a peptide or protein used for imaging or) appears on 154 US grants and 271 published applications in this corpus.
Search patents in A61K- Granted patents
- 154
- Published applications
- 271
- Assignees
- 146
- Inventors
- 533
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2001 | 7 | 0 |
| 2002 | 0 | 4 |
| 2003 | 0 | 9 |
| 2004 | 2 | 8 |
| 2005 | 1 | 9 |
| 2006 | 0 | 4 |
| 2007 | 4 | 6 |
| 2008 | 2 | 14 |
| 2009 | 3 | 16 |
| 2010 | 1 | 18 |
| 2011 | 7 | 10 |
| 2012 | 6 | 6 |
| 2013 | 9 | 11 |
| 2014 | 9 | 9 |
| 2015 | 8 | 16 |
| 2016 | 12 | 20 |
| 2017 | 12 | 13 |
| 2018 | 6 | 18 |
| 2019 | 8 | 9 |
| 2020 | 17 | 17 |
| 2021 | 10 | 11 |
| 2022 | 7 | 9 |
| 2023 | 4 | 7 |
| 2024 | 9 | 11 |
| 2025 | 7 | 10 |
| 2026 | 3 | 6 |
By publication year. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Methods and compositions for delivery of agents across the blood-brain barrier29 Sep 2026US 12,747,269 B2The Brigham and Women S Hospital, Inc.
- Composition and method for in vivo assay of opioid receptors5 May 2026US 12,617,816 B2Trustees of Dartmouth College
- Method and system for preventing sore throat in humans27 Jan 2026US 12,533,312 B2Seed Health, Inc.
- Biosensor tattoos and uses therefor for biomarker monitoring23 Sep 2025US 12,420,073 B2Carnegie Mellon University
- Methods and compositions for delivery of agents across the blood-brain barrier26 Aug 2025US 12,398,181 B2The Brigham and Women S Hospital, Inc.
- Fluorescent sensors and methods of making and using1 Oct 2026US 2026/0295095 A1Howard Hughes Medical Institute
- Gas-filled structures and related compositions, methods and systems to image a target site28 May 2026US 2026/0144902 A1California Institute of Technology
- Synthetic cancer-specific promoters21 May 2026US 2026/0137812 A1EARLI Inc.
- Compositions and Methods for Assessing Kinase Activity19 Mar 2026US 2026/0077065 A1The Board of Trustees of the Leland Stanford Junior University
- Atp-independent bioluminescent reporter variants to improve in vivo imaging19 Mar 2026US 2026/0077068 A1University of Virginia Patent Foundation
Most cited
By later US patents
- Diagnostic/therapeutic agents having microbubbles coupled to one or more vectors228US 6,261,537 B1Nycomed Imaging AS · 2001
- Indicator compounds, devices comprising indicator compounds, and methods of making and using the same164US 11,951,186 B2Willow Laboratories, Inc. · 2024
- Targeted diagnostic/therapeutic agents having more than one different vectors95US 6,331,289 B1Nycomed Imaging AS · 2001
- Process for identifying cancerous and/or metastatic cells of a living organism76US 7,244,232 B2Biomed Solutions, LLC · 2007
- Nanoparticle delivery vehicle74US 7,332,586 B2North Carolina State University · 2008